Skip Navigation LinksHome > April 2012 - Volume 33 - Issue 3 > Ameliorating Attention Problems in Children With Sickle Cell...
Journal of Developmental & Behavioral Pediatrics:
doi: 10.1097/DBP.0b013e31824ba1b5
Original Articles

Ameliorating Attention Problems in Children With Sickle Cell Disease: A Pilot Study of Methylphenidate

Daly, Brian PhD*; Kral, Mary C. PhD; Brown, Ronald T. PhD; Elkin, David PhD§; Madan-Swain, Avi PhD; Mitchell, Monica PhD; Crosby, Lori PsyD; DeMatteo, David JD, PhD*; LaRosa, Angela MD; Jackson, Sherron MD

Collapse Box


Objective: This pilot study examined whether methylphenidate (MPH) was effective in enhancing cognitive performance and attention for children with sickle cell disease (SCD) with cerebrovascular complications who evidence attention problems. Methods: In this multisite, pilot study, we evaluated 2 separate double-blind controlled clinical trials, including a laboratory trial of the short-term efficacy of MPH, with the second study a 3-week home/school crossover trial evaluating the efficacy of MPH. The laboratory trial included 14 participants between the age of 7 and 16 years. Assessments included measures of sustained attention, reaction time, executive functions, and verbal memory. The home/school trial included 20 participants. The outcome measures were parent and teacher ratings of attention. The first study compared MPH with placebo, while the second trial compared placebo, low-dose (LD) MPH, and moderate-dose MPH. Results: In the laboratory trial, significant effects were revealed for measures of memory and inhibitory control. Parent and teacher reports from the home/school trial indicate that moderate-dose MPH produced superior improvement in attention relative to the placebo and LD MPH. Conclusions: Stimulant medication positively impacted select measures of memory and inhibitory control in some children with SCD. Attention, as rated by parent and teachers, was improved for a greater number of children and adolescents on higher doses of MPH relative to LD MPH and placebo. Stimulant medication may provide an effective intervention for some children with SCD and cerebrovascular complications who demonstrate attention problems.

© 2012 Lippincott Williams & Wilkins, Inc.

Follow Us



Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.